Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dimethyl fumarate regulates histone deacetylase expression in astrocytes.
Three-Month Test-Retest Reliability of Center of Pressure Motion During Standing Balance in Individuals with Multiple Sclerosis.
Understanding the Role of T Cells in CNS Homeostasis.
Management of women with multiple sclerosis through pregnancy and after childbirth.
Multiple sclerosis: association with HL-A3.
Multiple Sclerosis and Catastrophic Health Expenditure in Iran.
Central fatigue in multiple sclerosis: a review of the literature.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice.
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
A Complex Case of Neuro-Behçet's Disease in a Patient Previously Diagnosed with multiple Sclerosis: A Case Report.
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
Use of rituximab in multiple sclerosis: current progress and future perspectives.
Neurotrophic and Neuroprotective effects of muscle contraction.
Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling.
Some recent advances in multiple sclerosis.
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis.
Comparative effectiveness of early Natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis.
Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis.
CHMP determines dimethyl fumarate in TECFIDERA® to be a new active substance in the European Union

Pages